VF
ONSIW

Virtu Financial’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Virtu Financial’s Portfolio ONSIW Stock Details ONSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,755
Closed -$1K – 2533
2018
Q2 		$1K Buy
+13,755
New +$506 ﹤0.01% 1930
2017
Q4 		– Sell
-33,928
Closed -$4K – 3332
2017
Q3 		$4K Buy
+33,928
New +$4.34K ﹤0.01% 2446

Other funds holding ONSIW

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Virtu Financial's ONSIW Position: Q3 2018 in Review

Virtu Financial sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q3 2018, closing a stake of 13,755 shares — an estimated $1K sold.

Virtu Financial first reported a position in ONSIW in Q3 2017 and held it in 2 quarters. The position peaked at $4K in Q3 2017. 6 funds tracked by Wall St. Rank hold ONSIW as of Q3 2018.

  • Virtu Financial reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q3 2018 after selling out during the quarter.
  • Virtu Financial sold 13,755 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q3 2018, an estimated $1K.
  • Virtu Financial first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q3 2017 and held it in 2 quarters.
  • Virtu Financial's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $4K in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q3 2018.

Based on Virtu Financial's 13F filing for Q3 2018, filed 13 Nov 2018.